AMWL American Well Corp
Price Chart
Executive Summary
American Well filed a DEFA14A supplement to its 2026 proxy statement, announcing that co-founder Dr. Roy Schoenberg will not stand for re-election as a Class III director at the annual meeting and that the board will not nominate a substitute. This follows his recent resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin, continuing a pattern of board turnover at the $146M market cap telehealth company.
Actionable Insight
Monitor for further board departures or potential activist interest given the ongoing turnover. The annual meeting outcome is unlikely to be materially affected, but the lack of a replacement nominee may signal difficulty in attracting qualified directors.
Key Facts
- Dr. Roy Schoenberg, co-founder and former Executive Vice Chairman, will not stand for re-election as a Class III director at the 2026 annual meeting.
- The board will not nominate a substitute candidate for the vacant seat.
- Votes cast on Schoenberg's re-election proposal will not be counted.
- This follows Schoenberg's resignation from the board on May 6, 2026, and the earlier resignation of director Dr. Peter Slavin.
- The supplement updates the definitive proxy statement filed April 23, 2026.
Financial Impact
No direct financial impact; board composition change at a $146M market cap company with no substitute nominee.
Risk Factors
- Continued board departures could signal governance instability or internal disagreements.
- No substitute nominee may reduce board diversity or expertise, potentially impacting strategic oversight.
- Shareholder dissatisfaction could emerge if the board fails to fill vacancies promptly.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000950103-26-008695 |
| Document: 0000950103-26-008695-index-headers.html | 0000950103-26-008695 |
| Document: 0000950103-26-008695-index.html | 0000950103-26-008695 |
| Document: 0000950103-26-008695.txt | 0000950103-26-008695 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
3d ago
|
DEFA14A
| $8.33 awaiting T+1 | awaiting T+1 | — | $9.11 (+9.43%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $8.65 $8.53 | ▼ −1.39% | ▲ +1.21% | $9.11 (+5.31%) |
|
Jun 1, 2026
11d ago
|
144
| $8.35 $8.18 | ▼ −2.04% | ▼ −1.31% | $9.11 (+9.09%) |
|
May 18, 2026
26d ago
|
Press Release
| $7.60 $7.71 | ▲ +1.45% | ▲ +2.10% | $9.11 (+19.85%) |
|
May 12, 2026
4w ago
|
8-K
| $7.69 $7.53 | ▼ −2.08% | ▼ −2.66% | $9.11 (+18.45%) |
|
May 5, 2026
5w ago
|
8-K
| $6.99 $7.58 | ▲ +8.44% | ▲ +8.77% | $9.11 (+30.31%) |
|
Apr 23, 2026
7w ago
|
DEFA14A
| $5.95 $5.80 | ▼ −2.52% | ▼ −3.31% | $9.11 (+53.08%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $5.28 $5.14 | ▲ +2.65% | ▲ +1.74% | $9.11 (−72.51%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $5.28 $5.14 | ▼ −2.65% | ▼ −1.74% | $9.11 (+72.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access